UnknownPhase 4NCT04054128

Bicarbonate vs Heparin Catheter Lock in Chronic Hemodialysis Patients

Studying Complication in hemodialysis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Hospital General "Dr. Miguel Silva" de Morelia
Principal Investigator
Israel Campos, M.D.
Hospital General "Dr. Miguel Silva" de Morelia
Intervention
Sodium Bicarbonate 7.5% Injection(drug)
Enrollment
60 target
Eligibility
18-65 years · All sexes
Timeline
20192020

Study locations (1)

Collaborators

Universidad Nacional Autonoma de Mexico · NAUSLIFE HEMODIALYSIS CLINICS

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04054128 on ClinicalTrials.gov

Other trials for Complication in hemodialysis

Additional recruiting or active studies for the same condition.

See all trials for Complication in hemodialysis

← Back to all trials